$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Hematology
Hematology
艾曲波帕治疗血小板减少的安全性
2025-10-19 11:44:20
Check Details
艾曲波帕可降低血小板减少患者的出血率
2025-10-19 11:44:20
Check Details
艾曲波帕联合标准的免疫疗法治疗SAA患者
2025-10-19 11:44:20
Check Details
艾曲波帕慢性ITP患者的特效药
2025-10-19 11:44:20
Check Details
慢性丙型肝炎血小板减少症患者可以服用艾曲波帕
2025-10-19 11:44:20
Check Details
艾曲波帕治疗特发性血小板减少症紫癜的的药效
2025-10-19 11:44:20
Check Details
艾曲波帕在慢性复发或难治特发性血小板减少性紫癜的疗效
2025-10-19 11:44:20
Check Details
艾曲波帕在继发于丙型肝炎病毒相关性肝硬化的血小板减少的疗效
2025-10-19 11:44:20
Check Details
食物和抗酸剂对艾曲波帕吸收的影响
2025-10-19 11:44:20
Check Details
艾曲波帕是一种酶诱导剂或拟制剂
2025-10-19 11:44:20
Check Details
艾曲波帕在化疗所致的血小板减少症的疗效
2025-10-19 11:44:20
Check Details
艾曲波帕治疗血小板减少的疗效如何?
2025-10-19 11:44:20
Check Details
1
2
...
841
842
843
844
845
846
847
...
940
941
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
How to Take Selinexor: Dosing, Food, and Safety
2
Avatrombopag vs Eltrombopag in ITP: Onset, Dosing Rules and Pre‑Procedure Use
3
Gilteritinib and Differentiation Syndrome in AML: Recognition, Emergency Management and Monitoring
4
Key points for drug monitoring of Molotinib in bone marrow fibrosis
5
Momelotinib for Myelofibrosis: Spleen Response, Symptom Improvement and Efficacy Monitoring
6
Pirtobrutinib and Risks of Atrial Fibrillation and Bleeding: Mechanism, Data Interpretation and Monitoring
7
Ixazomib (Ninlaro) Dosing Schedule, Missed Dose Management and Cycle Planning in 28‑Day Regimen
8
Ponatinib in the PACE Phase II Trial: Response Data in Resistant CML and Ph+ ALL
9
Anagrelide Cautions and Contraindications: Allergy, Hepatic, Cardiac and Bleeding Risks
10
Revumenib: Key Considerations Before and During Treatment
11
Pacritinib in Myelofibrosis: Evidence on Spleen Volume Reduction and Symptom Control
12
Pomalidomide vs Thalidomide: IMiD Generation Gap and MM Use